Skip to main content
Home

Main navigation

  • Home
  • News
  • About HIV
  • About us
Search
Donate
Donate now

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you.

I am a UK taxpayer and I understand that if I pay less Income and /or Capital Gains Tax than the amount of Gift Aid claimed on all my donations in the relevant tax year, it is my responsibility to pay any difference.

In our 35th year we’re asking people to donate £35 – that’s just £1 for every year we’ve been providing life-changing information. Any donation you make helps us continue our work towards a world where HIV is no longer a threat to health or happiness.

  • £5 allows us to reach millions of people globally with accurate and reliable resources about HIV prevention and treatment.
  • £10 helps us produce news and bulletins on the latest developments in HIV for healthcare staff around the world.
  • £35 means we can empower more people living with HIV to challenge stigma with our information workshops, videos and broadcasts.
HIV news videos

IAS 2017: HIV Community Forum

Primary tabs

  • View(active tab)
  • Preview
23 August 2017

Our HIV Community Forum shared information on HIV treatment and prevention from the 9th IAS Conference on HIV Science. With Dr Tristan Barber, from Chelsea and Westminster NHS Foundation Trust; Memory Sachikonye, from UK Community Advisory Board (UK-CAB); and Gus Cairns and Roger Pebody, from NAM aidsmap.

Related topics
Undetectable viral load & treatment as prevention
New & experimental HIV treatments
PrEP science
Self-testing & home testing
Global health targets
Transmission & prevention
PrEP
HIV treatment
Facebook
Twitter
LinkedIn
Print
Subscribe to emails & news feeds

Read more

Undetectable viral load & treatment as prevention

Undetectable viral load and transmission – information for people with HIV

PrEP

Pre-exposure prophylaxis (PrEP)

Self-testing & home testing

Home HIV testing (self-testing and self-sampling)

Key studies

Undetectable viral load & treatment as prevention

International study of gay couples reports no transmissions from an HIV-positive partner on treatment

New & experimental HIV treatments

New integrase inhibitor bictegravir works well for first-line HIV treatment

Global health targets

World on track to reach the 90-90-90 targets for HIV treatment by 2020

Self-testing & home testing

High uptake of HIV self-testing by female sex workers in African countries

PrEP science

Ipergay trial: PrEP still protected people who had less sex and used it less often

About us

NAM is a charity based in the United Kingdom. We work to change lives by sharing information about HIV & AIDS. We believe independent, clear and accurate information is vital in the fight against HIV & AIDS.

Our information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.

Read more about us

Connect with us

  • Twitter
  • Facebook
  • YouTube
  • Instagram
Subscribe to emails & newsfeeds

Login to our clinic portal
Donate

Visit NAM’s other websites: clinic.nam.org.uk | infohep.org | prepineurope.org | about-hiv.info | pro-vich.info | hiv-lens.org

© NAM Publications 2022, all rights reserved. NAM is not responsible for the content of external websites.

Company limited by guarantee. Registered in England & Wales, number: 2707596. Registered charity, number: 1011220

Footer menu

Show — Footer menu Hide — Footer menu
  • Contact
  • Jobs
  • Terms of Use
  • Accessibility
  • Privacy Policy
  • Cookies
  • Manage cookies